Top compounds associated with response to MR1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.13 0.001
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.12 0.002
mRNA lapatinib gCSI pan-cancer AAC 0.19 0.002
mRNA AR-42 GDSC1000 pan-cancer AAC -0.11 0.003
mRNA Erlotinib gCSI pan-cancer AAC 0.19 0.003
mRNA lapatinib GDSC1000 pan-cancer AAC 0.18 0.003
mRNA Erlotinib CCLE pan-cancer AAC 0.15 0.004
mRNA GDC-0941 gCSI pan-cancer AAC 0.2 0.004
Download CSV